Rating History for Acumen Pharmaceuticals, Inc. (ABOS) by Lucid Capital Markets

More Stocks Rated by Lucid Capital Markets | Latest Ratings for ABOS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/17/2025 N/A New Coverage Buy
(N/A)		 6.00
(N/A)		 2.10
(3.31)		 57.62% Details